Novartis AG vs The Goldman Sachs Group, Inc.
Market cap comparison over time
Novartis AG
$267.9B
Rank #54
The Goldman Sachs Group, Inc.
$301.2B
Rank #49
Market Cap Over Time
Key Moments
- The Goldman Sachs Group, Inc. overtook Novartis AG by 2025
Year-by-Year Comparison
| Year | Novartis AG | The Goldman Sachs Group, Inc. | Leader |
|---|---|---|---|
| 2026 | $267.9B | $301.2B | The Goldman Sachs Group, Inc. |
| 2025 | $227.3B | $255.6B | The Goldman Sachs Group, Inc. |
| 2024 | $177.6B | $163.2B | Novartis AG |
| 2023 | $163.8B | $107.8B | Novartis AG |
| 2022 | $146.3B | $93.0B | Novartis AG |
| 2021 | $134.5B | $100.5B | Novartis AG |
| 2020 | $134.7B | $68.0B | Novartis AG |
| 2019 | $142.4B | $58.3B | Novartis AG |
| 2018 | $110.8B | $41.5B | Novartis AG |
| 2017 | $104.0B | $62.4B | Novartis AG |
| 2016 | $89.6B | $57.9B | Novartis AG |
| 2015 | $100.4B | $42.9B | Novartis AG |
| 2014 | $103.4B | $45.6B | Novartis AG |
| 2013 | $76.6B | $41.1B | Novartis AG |
| 2012 | $59.2B | $29.2B | Novartis AG |
| 2011 | $52.5B | $20.4B | Novartis AG |
| 2010 | $51.1B | $37.4B | Novartis AG |
| 2009 | $50.7B | $37.2B | Novartis AG |
| 2008 | $44.5B | $18.4B | Novartis AG |
| 2007 | $50.6B | $46.4B | Novartis AG |
| 2006 | $55.9B | $42.8B | Novartis AG |
| 2005 | $53.9B | $27.2B | Novartis AG |
| 2004 | $43.8B | $21.9B | Novartis AG |
| 2003 | $42.0B | $20.6B | Novartis AG |
| 2002 | $36.9B | $14.1B | Novartis AG |
| 2001 | $43.1B | $19.0B | Novartis AG |
| 2000 | $50.7B | $21.8B | Novartis AG |
| 1999 | $40.7B | $19.1B | Novartis AG |